| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 76.67 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : 0.46 |
EPS(TTM) : 20.69 |
|
Book Value(₹) : 203.39 |
Market Cap(₹Cr) : 21,607.40 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,704.03 | 1,528.28 | 1,340.37 | 1,215.73 | 1,108.83 |
| Other Income | 35.51 | 34.83 | 17.26 | 28.99 | 10.00 |
| Stock Adjustments | 43.54 | 13.15 | -8.50 | -2.49 | 12.57 |
| Total Income | 1,783.08 | 1,576.26 | 1,349.13 | 1,242.23 | 1,131.40 |
| EXPENDITURE : | |||||
| Raw Materials | 542.79 | 293.31 | 227.88 | 197.16 | 211.08 |
| Power and Fuel Cost | 4.10 | 4.46 | 4.41 | 4.01 | 3.89 |
| Other Manufacturing Expenses | 22.35 | 16.80 | 11.50 | 7.47 | 7.16 |
| Selling and Administration Expenses | 223.80 | 319.27 | 242.67 | 215.51 | 181.66 |
| Miscellaneous Expenses | 106.06 | 122.10 | 87.78 | 84.93 | 93.13 |
| Employee Benefit Expenses | 361.92 | 331.67 | 252.52 | 220.11 | 207.02 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 522.06 | 488.65 | 522.38 | 513.04 | 427.47 |
| Interest | 220.24 | 57.42 | 20.81 | 3.05 | 0.94 |
| Gross Profit | 301.82 | 431.23 | 501.57 | 509.99 | 426.53 |
| Depreciation | 181.77 | 102.39 | 64.66 | 51.46 | 37.64 |
| Profit Before Tax | 120.05 | 328.84 | 436.91 | 458.53 | 388.89 |
| Current Tax | 21.98 | 57.64 | 76.50 | 80.17 | 70.18 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 20.68 | -28.52 | -37.59 | -38.83 | -31.90 |
| Reported Net Profit | 77.39 | 299.72 | 398.01 | 417.19 | 350.61 |
| Extraordinary Items | 1.35 | 2.79 | 5.17 | -1.72 | 2.33 |
| Adjusted Net Profit | 76.04 | 296.93 | 392.84 | 418.91 | 348.28 |
| Adjustment below Net Profit | -2.84 | -2.76 | -0.15 | -1.01 | -1.28 |
| Profit/Loss Balance carried down | 2,487.17 | 2,190.21 | 1,892.28 | 1,557.74 | 1,283.09 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 100.06 | 0.00 | 99.93 | 81.65 | 74.68 |
| P & L Balance carried down | 2,461.66 | 2,487.17 | 2,190.21 | 1,892.28 | 1,557.74 |
| Dividend | 0.00 | 0.00 | 99.93 | 81.65 | 74.68 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 735.00 | 0.00 | 735.00 | 601.00 | 550.00 |
| Dividend Per Share(Rs) | 7.35 | 0.00 | 7.35 | 6.01 | 5.50 |
| Earnings Per Share-Unit Curr | 5.68 | 22.04 | 29.27 | 30.69 | 25.82 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 184.65 | 185.59 | 163.39 | 141.11 | 116.03 |
| Book Value(Adj)-Unit Curr | 184.65 | 185.59 | 163.39 | 141.11 | 116.03 |